{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"CDH1 (E-cadherin), a tumor suppressor involved in cell adhesion, is altered by mutation or deletion in various cancer typess, most frequently in breast and esophagogastric cancers.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"11/16/2020",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "12588804"
      ]
    },
    "description":"The CDH1 T340A mutation is located in the extracellular domain of the protein. This mutation has been found as a germline mutation in gastric cancer (PMID: 12588804). Expression of this mutation in a hamster ovary cell line demonstrated that it is inactivating as measured by decreased cell aggregation and increased cell invasion and migration compared to wildtype (PMID: 12588804).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"T340M",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":999,
    "hgvs":null,
    "hugoSymbol":"CDH1",
    "id":null,
    "proteinEnd":340,
    "proteinStart":340,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The CDH1 T340M mutation has not been functionally or clinically validated. However, CDH1 T340A is known to be oncogenic, and therefore CDH1 T340M is considered likely oncogenic.",
  "vus":false
}